Serum and CSF levels of NfL are correlated in a variety of neurodegenerative diseases, including Guillain-Barré syndrome (GBS), ALS, and AD, where the CSF levels are about 100 times higher than the serum (Gaiottino et al., 2013). This evidence concerns the gene NEFL and Guillain-Barre syndrome.